type
interferon
ifni
broad
famili
cytokin
central
innat
immun
respons
protein
long
appreci
critic
role
play
restrain
viral
infect
shape
antivir
immun
respons
howev
recent
year
increas
awar
immunosuppress
action
protein
well
mani
current
therapeut
applic
manipul
ifni
pathway
limit
understand
mechan
therapi
actual
function
review
highlight
divers
tempor
impact
ifni
signal
discuss
current
therapeut
use
ifni
explor
strategi
block
ifni
allevi
immun
dysfunct
persist
viru
infect
hand
specif
subset
immun
cell
abl
detect
viru
even
infect
via
express
pattern
recognit
molecul
toll
like
receptor
tlr
turn
stimul
robust
ifni
respons
viru
sens
anoth
level
divers
speci
ifni
produc
ifn
famili
consist
seven
class
total
best
understood
subtyp
singl
protein
interferon
k
also
present
although
entir
cytokin
famili
signal
singl
dimer
receptor
ifnar
evid
individu
subtyp
ifni
differenti
interact
subunit
potenti
result
uniqu
downstream
effect
exampl
speci
high
affin
trigger
enhanc
antivir
activ
recent
describ
associ
signal
independ
suggest
potenti
elev
potenc
ifnar
lack
intrins
signal
abil
canon
reli
associ
janu
kinas
jak
signal
transduc
activ
transcript
stat
protein
enact
express
interferon
stimul
gene
isg
signal
diversifi
level
via
potenti
activ
dimer
multipl
differ
stat
molecul
ifnar
receptor
ligat
typic
autophophoryl
result
activ
howev
certain
cell
type
also
phosphoryl
respons
signal
activ
stat
associ
one
nine
differ
irf
protein
activ
common
nonoverlap
gene
express
profil
ifni
also
activ
altern
signal
pathway
map
kinas
other
diversifi
respons
famili
cytokin
end
outcom
ifni
signal
activ
isg
activ
antivir
immunomodulatori
function
multipl
level
divers
ifni
system
allow
integr
variou
signal
within
immun
cellular
environ
modul
tailor
ifn
respons
control
pathogen
hand
understand
specif
integr
signal
play
given
diseas
state
critic
deciph
activ
singl
cytokin
system
lead
control
divers
pathogen
importantli
critic
develop
target
therapeut
manipul
ifni
treat
divers
type
diseas
multipl
downstream
effect
ifni
push
pull
immun
respons
ifni
initi
character
abil
interfer
viral
infect
chicken
chorioallantioc
membran
howev
year
sinc
knowledg
direct
antivir
role
protein
well
abil
modul
innat
adapt
immun
blossom
promin
antivir
isg
downstream
ifnar
code
protein
doubl
strand
rnaactiv
enzym
protein
kinas
pkr
mx
protein
bind
directli
critic
viral
compon
inhibit
function
wherea
pkr
oa
interfer
viral
replic
via
blockad
cellular
transcript
protein
synthesi
machineri
gene
power
induc
ifni
express
along
ifni
induc
gene
often
use
gaug
ifni
signal
multipl
diseas
infecti
state
cumul
refer
interferon
signatur
genet
defici
singl
one
protein
confer
increas
suscept
infect
residu
antivir
activ
remain
anim
ablat
three
pathway
indic
addit
antivir
mechan
stimul
ifni
supplementari
direct
antivir
effect
ifni
also
modul
innat
adapt
immun
respons
pathogen
ifni
dictat
immun
environ
signal
directli
immun
cell
indirectli
via
alter
cytokin
chemokin
milieu
ifni
play
critic
role
vivo
expans
cell
respons
matur
mainten
cell
respons
directli
indirectli
via
enhanc
antigen
present
cell
apc
yet
ifni
effect
uncondit
posit
also
mani
immunoregulatori
even
immunosuppress
action
cytokin
exampl
ifni
signal
express
immunoregulatori
cytokin
flu
infect
dampen
cell
respons
restrict
immunopatholog
similarli
therapeut
treatment
patient
multipl
sclerosi
lead
increas
level
well
enhanc
express
monocyt
allow
silenc
autoreact
cell
respons
immunoregulatori
effect
ifni
signal
like
evolv
preserv
homeostasi
within
immun
system
organ
overal
incred
divers
downstream
effect
ifni
signal
coordin
specif
trigger
guid
distinct
effect
fulli
understood
ultim
molecular
cellular
understand
elicit
specif
outcom
ifni
signal
would
invalu
truli
har
ifn
therapeut
target
perhap
diseas
specif
manner
given
incred
pleiotrop
natur
ifni
perhap
surpris
amplifi
interf
pathway
attempt
therapeut
number
divers
diseas
indic
figur
major
ifni
interven
drug
market
involv
boost
level
cytokin
howev
block
antibodi
ifn
human
current
clinic
trial
interestingli
ifni
administr
acut
viral
infect
particularli
effect
test
sever
clinic
trial
respiratori
infect
overal
consensu
side
effect
noseble
preclud
use
ifni
therapi
clinic
acut
resolv
respiratori
infect
interestingli
studi
demonstr
given
prophylact
prevent
respiratori
infect
although
ineffect
given
therapeut
suggest
situat
bodi
natur
overcom
infect
late
treatment
ifni
may
enhanc
endogen
ifni
effect
case
persist
infect
therapeut
administr
ifni
highli
effect
situat
recombin
treatment
use
clinic
hepat
c
viru
hcv
infect
year
hcv
persist
viral
infect
lead
sever
fibrosi
cirrhosi
liver
current
standard
care
hcv
involv
administr
pegyl
combin
antivir
drug
ribavirin
howev
mani
patient
regim
ineffect
erad
hcv
infect
fact
ifni
treatment
lead
clearanc
hcv
entir
appar
mani
patient
respond
therapi
direct
antivir
properti
presum
respons
quench
viral
titer
howev
patient
fail
sustain
virolog
respons
follow
ribavirin
treatment
probabl
mani
reason
treatment
failur
one
common
characterist
patient
fail
therapi
initi
heighten
ifni
signatur
prior
onset
treatment
fail
substanti
increas
therapi
data
indic
certain
level
ifni
signal
reach
heighten
ad
suggest
situat
cell
subset
cell
encount
chronic
ifni
may
react
differ
ifni
remain
determin
ifni
affect
system
case
viral
clearanc
attain
particularli
whether
ifni
boost
detriment
enhanc
immunosuppress
immun
dysfunct
divers
outcom
common
signal
shed
light
tight
balanc
antivir
immun
inhibitori
effect
ifni
viru
infect
also
valu
assess
basal
ifn
signatur
patient
prior
initi
therapeut
treatment
manipul
ifni
level
also
shown
efficaci
reduc
viral
titer
certain
situat
hiv
infect
combin
antiretrovir
therapi
cart
highli
effect
reduc
hiv
titer
partial
resurrect
immun
system
infect
individu
howev
mani
case
ifni
signatur
remain
elev
even
patient
respond
cart
absenc
cart
treatment
alon
limit
viral
replic
although
treatment
continu
restrain
viral
replic
cohort
patient
suspend
cart
therapi
similar
situat
hcv
infect
chronic
ifni
signal
hiv
may
limit
alter
effect
ifn
therapi
cart
suppress
viral
replic
may
allow
immun
system
overcom
refract
ifni
signal
refresh
respons
system
benefici
effect
ifni
mechanist
understand
treatment
alon
fail
control
hiv
differenti
pathway
activ
ifni
cart
treat
untreat
patient
physiolog
paramet
improv
cart
facilit
efficaci
critic
design
success
ifn
interven
therapi
hiv
persist
viru
infect
therapeut
impact
ifni
treatment
multipl
dose
formul
use
treat
control
mani
type
cancer
includ
leukemia
melanoma
potenti
mani
pleiotrop
effect
ifni
could
play
role
treatment
diseas
includ
direct
inhibit
angiogenesi
tumor
prolifer
well
enhanc
antitumor
immun
respons
recent
appreci
role
host
ifni
product
efficaci
radiat
treatment
reveal
role
ifni
enhanc
dendrit
cell
prime
antitumor
cell
respons
ifni
therapi
melanoma
suppress
remnant
metastasi
success
patient
recent
remov
tumor
efficaci
drug
advanc
diseas
state
quit
poor
hypothes
result
immun
skew
toward
profil
also
possibl
advanc
diseas
state
result
chronic
level
ifn
signal
trigger
immunosuppress
similar
observ
persist
viru
infect
dosag
ifni
use
cancer
applic
significantli
higher
tempor
shorter
case
viral
diseas
may
favor
antiprolif
cytostat
effect
ifni
far
clinic
applic
ifni
discuss
attempt
exploit
immun
stimulatori
effect
ifni
howev
case
multipl
sclerosi
ms
progress
inflammatori
diseas
central
nervou
system
commonli
treat
recombin
therapi
immunoregulatori
effect
ifni
like
critic
therapi
ms
use
sinc
proven
effect
preserv
blood
brain
barrier
integr
delay
instanc
diseas
relaps
improv
cognit
function
case
clinic
manipul
ifni
mechan
act
reliev
ms
unclear
although
consensu
reach
studi
implic
immunomodulatori
effect
critic
diseas
relief
one
studi
identifi
abil
reduc
proteolyt
enzym
destroy
blood
brain
barrier
integr
studi
highlight
abil
dampen
express
immunostimulatori
cytokin
trigger
immunosuppress
factor
notabl
thu
suppress
aspect
ifni
hinder
control
one
diseas
situat
highli
benefici
compar
analysi
ifni
system
could
lead
understand
suppress
stimulatori
mechan
engend
specif
target
har
therapeut
recent
two
independ
laboratori
demonstr
antibodi
blockad
quench
immun
activ
immunosuppress
facilit
clearanc
persist
lymphocyt
choriomening
viru
lcmv
administr
result
reduc
chronic
inflamm
ii
restor
immun
cellular
ie
increas
dendrit
cell
dc
macrophag
nk
cell
b
cell
cell
iii
enhanc
surviv
andor
mainten
cell
iv
increas
express
potenc
v
mainten
lymphoid
tissu
architectur
vi
reduc
express
multipl
factor
cell
type
inhibit
antivir
immun
eg
suppress
dc
indic
ifni
signal
drive
mani
immun
dysfunct
suppress
mechan
associ
persist
viru
infect
addit
neg
effect
antivir
aspect
ifni
sustain
indic
posit
neg
mechan
ifni
signal
simultan
present
figur
unlik
mice
never
control
lcmv
infect
transient
antibodi
blockad
ifnar
initi
onset
establish
persist
lcmv
infect
revers
immun
dysfunct
diminish
immunosuppress
program
ultim
lead
enhanc
control
persist
infect
mechanist
enhanc
control
upon
inhibit
ifni
signal
like
multifactor
improv
cellular
interact
spatial
organ
tissu
composit
type
apc
present
combin
decreas
suppress
signal
diminish
level
chronic
inflamm
elev
level
potenc
proinflammatori
factor
like
work
conjunct
facilit
acceler
control
persist
lcmv
infect
yet
persist
lcmv
infect
specif
control
upon
ifni
blockad
clear
sinc
enhanc
two
main
effector
mechan
directli
elimin
viru
infect
ie
virusspecif
cell
antibodi
observ
precis
mechan
stimul
ifni
signal
throughout
cours
persist
infect
ie
initi
burst
ifni
first
day
infect
ifni
differenti
induc
antivir
immunostimulatori
immunosuppress
function
ultim
downstream
mechan
ifni
target
potenti
viral
persist
still
unknown
activ
area
research
lead
import
insight
hostbas
mechan
underli
viral
persist
better
understand
therapi
might
har
clinic
acut
persist
lcmv
infect
initi
trigger
robust
ifni
respons
quantifi
circul
decreas
day
post
infect
acut
decreas
ifni
suggest
facilit
persist
prematur
ceas
antivir
control
aggress
virus
consist
notion
exogen
addit
ifni
genet
enhanc
ifni
onset
infect
augment
control
otherwis
persist
lcmv
infect
howev
administr
ifni
persist
establish
decreas
viru
titer
corrobor
highli
complex
tempor
natur
ifni
signal
toward
modul
immun
respons
control
viru
replic
non
cytopath
virus
hand
immun
system
stringent
requir
ifni
signal
contain
cytopath
virus
capabl
induc
sever
patholog
throughout
cours
infect
result
major
concern
type
therapeut
strategi
aim
inhibit
ifni
activ
enhanc
suscept
reactiv
cytopath
virus
absenc
ifni
contain
becom
lifethreaten
critic
caveat
must
heavili
weigh
close
monitor
interferon
block
therapi
hiv
mani
way
diseas
immun
activ
review
uncheck
immun
activ
hiv
associ
multipl
immunolog
dysfunct
includ
aberr
cell
activ
dysfunct
b
cell
respons
polyclon
b
cell
activ
alter
innat
immun
capac
disrupt
lymphoid
architectur
increas
morbid
mortal
hiv
coinfect
pathogen
review
root
caus
elev
activ
state
still
unknown
ifni
emerg
key
compon
fact
quit
bit
correl
evid
reduc
ifni
signal
would
benefit
diseas
outcom
persist
infect
hiv
exampl
although
african
green
monkey
rhesu
macaqu
develop
persist
siv
infect
siv
infect
rare
caus
aid
african
green
monkey
wherea
rhesu
macaqu
progress
aid
similarli
hiv
infect
human
major
differ
infect
lack
sustain
ifni
gene
express
signatur
african
green
monkey
seen
rhesu
macaqu
siv
infect
similar
dichotomi
ifni
signal
observ
hiv
progressor
longterm
nonprogressor
although
may
effect
decreas
hiv
titer
oppos
caus
nonprogressor
phenotyp
strategi
indirectli
studi
expos
dualiti
ifni
signal
possess
capac
simultan
drive
antivir
immun
stimulatori
function
also
induc
mani
suppress
factor
associ
persist
viru
infect
figur
posit
neg
effect
ifni
signal
simultan
may
tempor
import
antivir
immun
enhanc
impact
domin
earli
give
way
later
time
point
domin
detriment
effect
chronic
ifni
stimul
although
import
note
antivir
effect
ifni
still
ongo
throughout
infect
understand
tempor
reaction
ifni
mediat
perplex
could
due
varieti
chang
immun
respons
persist
infect
progress
includ
alter
cell
type
present
cell
react
ifni
context
factor
present
later
stage
infect
andor
switch
ifni
subtyp
produc
name
constant
enhanc
repress
immun
respons
persist
undoubtedli
manifest
directli
indirectli
like
weight
differ
differ
cell
type
howev
mechan
distinctli
drive
posit
neg
effect
ifni
signal
uncoupl
may
possibl
maintain
antivir
immun
stimulatori
effect
ifni
inhibit
suppress
effect
multipl
immunosuppress
factor
driven
ifni
persist
infect
block
ifni
signal
could
simultan
abrog
signal
root
also
diminish
chronic
activ
continu
wear
alreadi
overstimul
immun
respons
given
ifni
signal
critic
control
viru
infect
blockad
may
foster
secondari
viru
infect
enhanc
patholog
cytopath
virus
recent
phase
trial
use
ifnar
block
antibodi
patient
system
sclerosi
antibodi
direct
system
lupu
erthematosu
report
increas
incid
infect
least
rel
short
period
studi
month
yet
possibl
enhanc
suscept
secondari
viral
infect
upon
ifni
blockad
particularli
hiv
infect
ie
alreadi
debilit
immun
environ
close
monitor
incred
pleiotrop
effect
ifni
necessit
finetun
potenti
therapeut
agent
although
extens
knowledg
divers
signal
pathway
activ
ifni
link
specif
pathway
discret
outcom
well
understood
box
exampl
time
dissect
specif
signal
transduct
event
lead
express
immunosuppress
molecul
versu
express
antivir
molecul
immun
enhanc
pathway
fulli
understand
individu
contribut
differ
ifni
famili
member
target
prevent
specif
aspect
ifni
signal
eg
inhibit
ifni
type
drive
suppress
function
ifni
preserv
mediat
antivir
immun
enhanc
effect
achiev
would
import
advanc
block
entir
ifni
system
ie
ifnar
thoroughli
explor
persist
viru
infect
ifn
signatur
given
diseas
state
mani
correl
immun
dysfunct
demonstr
lcmv
hiv
role
ifni
hiv
immun
dysfunt
yet
clearli
defin
therefor
whether
block
ifni
similarli
enhanc
immun
function
allow
control
hiv
infect
remain
seen
lowlevel
chronic
immun
activ
potenti
part
mediat
ifni
signal
ongo
mani
patient
cart
suppress
hiv
replic
situat
ifni
blockad
may
use
halt
ongo
immun
deterior
ideal
understand
enhanc
block
ifni
pathway
facilit
translat
excit
therapeut
concept
clinic
realiti
type
interferon
ifni
underli
mani
immun
dysfunct
associ
persist
viru
infect
ifni
simultan
critic
antivir
immunomodulatori
function
viral
persist
block
ifni
mous
model
enhanc
immun
respons
control
persist
viru
infect
therapeut
interf
ifni
signal
could
help
treat
multipl
diseas
state
multipl
ifni
interf
drug
current
avail
clinic
mani
pipelin
major
ifni
therapi
aim
amplifi
ifni
signal
depict
green
howev
prospect
therapi
block
ifni
red
emerg
precis
molecular
mechan
action
unknown
case
effect
ifni
therapi
sever
diseas
indic
indic
throughout
cours
viral
infect
ifni
simultan
drive
antivir
proimmun
pathway
shown
green
arrow
addit
express
immunosuppress
factor
immunopatholog
shown
red
arrow
end
outcom
ifni
signal
like
determin
multitud
factor
work
concert
portion
indic
purpl
cours
normal
infect
necessari
control
initi
viral
replic
adapt
immun
ramp
dampen
antivir
immun
respons
viru
clear
howev
viru
replic
abl
persist
face
ifni
respons
antivir
immun
enhanc
impact
ifni
retain
reason
current
unclear
suppress
mechan
becom
domin
lead
mani
cellular
tissu
dysfunct
associ
persist
viru
infect
